UNI-MB - logo
UMNIK - logo
 

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov UM. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 75
1.
  • EuroInf 2: Subthalamic stim... EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
    Dafsari, Haidar S.; Martinez‐Martin, Pablo; Rizos, Alexandra ... Movement disorders, March 2019, Letnik: 34, Številka: 3
    Journal Article
    Recenzirano
    Odprti dostop

    Objective Real‐life observational report of clinical efficacy of bilateral subthalamic stimulation (STN‐DBS), apomorphine (APO), and intrajejunal levodopa infusion (IJLI) on quality of life, motor, ...
Celotno besedilo

PDF
2.
  • Continuous Subcutaneous Apo... Continuous Subcutaneous Apomorphine Infusion in Parkinson’s Disease: A Single-Center, Long-Term Follow-Up Study of the Causes for Discontinuation
    Henriksen, Tove; Staines, Harry Journal of personalized medicine, 06/2021, Letnik: 11, Številka: 6
    Journal Article
    Recenzirano
    Odprti dostop

    (1) Background: Subcutaneous apomorphine infusion (SCAI) is one of the three main treatment options for motor fluctuations in advanced Parkinson’s disease (PD). The adherence to SCAI is generally ...
Celotno besedilo

PDF
3.
  • Close relationships in Park... Close relationships in Parkinson´s disease patients with device‐aided therapy
    Scharfenort, Monica; Timpka, Jonathan; Sahlström, Thomas ... Brain and behavior, June 2021, Letnik: 11, Številka: 6
    Journal Article
    Recenzirano
    Odprti dostop

    Objectives Deep brain stimulation, continuous subcutaneous apomorphine infusion, and levodopa–carbidopa intestinal gel infusion, together called device‐aided therapies (DAT), are introduced when oral ...
Celotno besedilo

PDF
4.
  • Viewpoint and practical rec... Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease
    Odin, Per; Chaudhuri, K Ray; Volkmann, Jens ... NPJ Parkinson's Disease, 2018, Letnik: 4, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    Motor aspects of Parkinson's disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of "wearable" technologies, but practical guidance on objective measurement (OM) ...
Celotno besedilo

PDF
5.
  • Hot and Cold Cognitive Dist... Hot and Cold Cognitive Disturbances in Parkinson Patients Treated with DBS-STN: A Combined PET and Neuropsychological Study
    Jørgensen, Louise M; Henriksen, Tove; Mardosiene, Skirmante ... Brain sciences, 05/2022, Letnik: 12, Številka: 5
    Journal Article
    Recenzirano
    Odprti dostop

    Patients with Parkinson's disease (PD) often suffer from non-motor symptoms, which may be caused by serotonergic dysfunction. Deep Brain Stimulation (DBS) in the subthalamic nucleus (STN) may also ...
Celotno besedilo
6.
  • Interdisciplinary recognizi... Interdisciplinary recognizing and managing of drug‐induced tardive oromandibular dystonia: two case reports
    Bakke, Merete; Henriksen, Tove; Biernat, Heidi Bryde ... Clinical case reports, November 2018, Letnik: 6, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    Key Clinical Message Tardive dystonia is a risk factor in medical antipsychotic treatment. It often begins with repetitive involuntary jaw and tongue movements resulting in impaired chewing and ...
Celotno besedilo

PDF
7.
  • Spinal cord stimulation the... Spinal cord stimulation therapy for patients with Parkinson’s disease and gait problems (STEP-PD): study protocol for an exploratory, double-blind, randomised, placebo-controlled feasibility trial
    Hvingelby, Victor S; Højholt Terkelsen, Miriam; Johnsen, Erik L ... BMJ neurology open, 08/2022, Letnik: 4, Številka: 2
    Journal Article
    Recenzirano
    Odprti dostop

    IntroductionGait difficulties are common in Parkinson’s disease (PD) and cause significant disability. These symptoms are often resistant to treatment. Spinal cord stimulation (SCS) has been found to ...
Celotno besedilo
8.
  • Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians
    Henriksen, Tove Neurodegenerative disease management, 06/2014, Letnik: 4, Številka: 3
    Journal Article
    Recenzirano

    Apomorphine was introduced before the era of levodopa as a treatment for idiopathic Parkinson's disease (iPD). A number of practical obstacles were to be solved before a wider use of the drug was ...
Preverite dostopnost
9.
  • Apomorphine subcutaneous in... Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
    Katzenschlager, Regina; Poewe, Werner; Rascol, Olivier ... Lancet neurology, 09/2018, Letnik: 17, Številka: 9
    Journal Article
    Recenzirano
    Odprti dostop

    Subcutaneous apomorphine infusion is a clinically established therapy for patients with Parkinson's disease with motor fluctuations not optimally controlled by oral medication. Open-label studies ...
Celotno besedilo

PDF
10.
  • Practical use of apomorphin... Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience
    Henriksen, Tove; Katzenschlager, Regina; Bhidayasiri, Roongroj ... Journal of Neural Transmission, 11/2023, Letnik: 130, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    Subcutaneous apomorphine infusion is a device-aided therapy for Parkinson’s disease that can be considered when motor fluctuations become persistent and are no longer adequately controlled by ...
Celotno besedilo
1 2 3 4 5
zadetkov: 75

Nalaganje filtrov